Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Predicta Med
Costa Mesa, California, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Predicta Med aims to improve the early detection and treatment selection of autoimmune diseases using AI-driven analytics. It aggregates and analyzes EMR and claims data to identify patients at risk and provide actionable insights for healthcare providers.
- Therapeutic areas
- GastroenterologyNeurologyImmunologyRheumatology
- Modalities
- AI-driven predictive analytics
- Industry
- Digital Health Medical Devices
02
Partnerships
Partnerships with Stanford Medicine, Mayo Clinic, and other prestigious healthcare institutions.
Beyond the preview
Go deeper on Predicta Med.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Predicta Med.